Skip to main content
Erschienen in: Journal of Neurology 9/2017

29.07.2017 | Original Communication

Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies

verfasst von: Stojan Peric, Ruzica Maksimovic, Bojan Banko, Milica Durdic, Bogdan Bjelica, Ivo Bozovic, Yunus Balcik, Jovan Pesovic, Dusanka Savic-Pavicevic, Vidosava Rakocevic-Stojanovic

Erschienen in: Journal of Neurology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Magnetic resonance imaging (MRI) of muscles has recently become a significant diagnostic procedure in neuromuscular disorders. There is a lack of muscle MRI studies in patients with myotonic dystrophy type 1 (DM1), especially type 2 (DM2). To analyze fatty infiltration of leg muscles, using 3.0 T MRI in patients with genetically confirmed DM1 and DM2 with different disease durations. The study comprised 21 DM1 and 10 DM2 adult patients. Muscle MRI was performed in axial plane of the lower limbs using T1-weighted (T1w) sequence. Six-point scale by Mercuri et al. was used. Fatty infiltration registered in at least one muscle of lower extremities was found in 71% of DM1 and 40% of DM2 patients. In DM1 patients, early involvement of the medial head of gastrocnemius and tibialis anterior muscles was observed with later involvement of other lower leg muscles and of anterior and posterior thigh compartments with relative sparing of the rectus femoris. In DM2, majority of patients had normal MRI findings. Early involvement of lower legs and posterior thighs was found in some patients. Less severe involvement of the medial head of the gastrocnemius compared to other lower leg muscles was also observed, while involvement of proximal muscles was rather diffuse than selective. It seems that both in DM1 and DM2 some muscles may be affected before weakness is clinically noted and vice versa. We described characteristic pattern and way of progression of muscle involvement in DM1 and DM2.
Literatur
1.
Zurück zum Zitat Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11:891–905CrossRefPubMed Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11:891–905CrossRefPubMed
2.
Zurück zum Zitat Turner C, Hilton-Jones D (2014) Myotonic dystrophy: diagnosis, management and new therapies. Curr Opin Neurol 27(5):599–606CrossRefPubMed Turner C, Hilton-Jones D (2014) Myotonic dystrophy: diagnosis, management and new therapies. Curr Opin Neurol 27(5):599–606CrossRefPubMed
4.
Zurück zum Zitat Straub V, Carlier PG, Mercuri E (2012) TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25–26 February 2011, Rome, Italy. Neuromuscul Disord 22(Suppl 2):S42–S53CrossRefPubMed Straub V, Carlier PG, Mercuri E (2012) TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25–26 February 2011, Rome, Italy. Neuromuscul Disord 22(Suppl 2):S42–S53CrossRefPubMed
5.
Zurück zum Zitat Schedel H, Reimers CD, Nägele M, Witt TN, Pongratz DE, Vogl T (1992) Imaging techniques in myotonic dystrophy. A comparative study of ultrasound, computed tomography and magnetic resonance imaging of skeletal muscles. Eur J Radiol 15(3):230–238CrossRefPubMed Schedel H, Reimers CD, Nägele M, Witt TN, Pongratz DE, Vogl T (1992) Imaging techniques in myotonic dystrophy. A comparative study of ultrasound, computed tomography and magnetic resonance imaging of skeletal muscles. Eur J Radiol 15(3):230–238CrossRefPubMed
6.
Zurück zum Zitat Hiba B, Richard N, Hébert LJ, Coté C, Nejjari M, Vial C et al (2012) Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI. J Magn Reson Imaging 35(3):678–685CrossRefPubMed Hiba B, Richard N, Hébert LJ, Coté C, Nejjari M, Vial C et al (2012) Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI. J Magn Reson Imaging 35(3):678–685CrossRefPubMed
7.
Zurück zum Zitat Damian MS, Bachmann G, Herrmann D, Dorndorf W (1993) Magnetic resonance imaging of muscle and brain in myotonic dystrophy. J Neurol 240(1):8–12CrossRefPubMed Damian MS, Bachmann G, Herrmann D, Dorndorf W (1993) Magnetic resonance imaging of muscle and brain in myotonic dystrophy. J Neurol 240(1):8–12CrossRefPubMed
8.
Zurück zum Zitat Hamano T, Kawamura Y, Mutoh T, Hirayama M, Kuriyama M (2010) Muscle MRI in myotonic dystrophy type 1 with foot drop. Eur Neurol 63(3):144–148CrossRefPubMed Hamano T, Kawamura Y, Mutoh T, Hirayama M, Kuriyama M (2010) Muscle MRI in myotonic dystrophy type 1 with foot drop. Eur Neurol 63(3):144–148CrossRefPubMed
9.
Zurück zum Zitat Kornblum C, Lutterbey G, Bogdanow M, Kesper K, Schild H, Schröder R et al (2006) Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 253(6):753–761CrossRefPubMed Kornblum C, Lutterbey G, Bogdanow M, Kesper K, Schild H, Schröder R et al (2006) Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 253(6):753–761CrossRefPubMed
10.
Zurück zum Zitat Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E et al (2010) MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 115(4):585–599CrossRefPubMed Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E et al (2010) MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 115(4):585–599CrossRefPubMed
11.
Zurück zum Zitat Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF et al (2012) Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 20(12):1203–1208CrossRefPubMedPubMedCentral Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF et al (2012) Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 20(12):1203–1208CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Savić Pavićević D, Miladinović J, Brkušanin M, Šviković S, Djurica S, Brajušković G et al (2013) Molecular genetics and genetic testing in myotonic dystrophy type 1. Biomed Res Int 2013:391821PubMedPubMedCentral Savić Pavićević D, Miladinović J, Brkušanin M, Šviković S, Djurica S, Brajušković G et al (2013) Molecular genetics and genetic testing in myotonic dystrophy type 1. Biomed Res Int 2013:391821PubMedPubMedCentral
13.
Zurück zum Zitat Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56(3):336–340CrossRefPubMed Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56(3):336–340CrossRefPubMed
14.
Zurück zum Zitat Peric S, Mandic-Stojmenovic G, Stefanova E, Savic-Pavicevic D, Pesovic J, Ilic V et al (2015) Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2. J Neurol 262(1):142–148CrossRefPubMed Peric S, Mandic-Stojmenovic G, Stefanova E, Savic-Pavicevic D, Pesovic J, Ilic V et al (2015) Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2. J Neurol 262(1):142–148CrossRefPubMed
15.
Zurück zum Zitat Mercuri E, Cini C, Counsell S, Allsop J, Zolkipli Z, Jungbluth H, Sewry C, Brown SC, Pepe G, Muntoni F (2002) Muscle MRI findings in a three-generation family affected by Bethlem myopathy. Eur J Paediatr Neurol 6(6):309–314CrossRefPubMed Mercuri E, Cini C, Counsell S, Allsop J, Zolkipli Z, Jungbluth H, Sewry C, Brown SC, Pepe G, Muntoni F (2002) Muscle MRI findings in a three-generation family affected by Bethlem myopathy. Eur J Paediatr Neurol 6(6):309–314CrossRefPubMed
16.
Zurück zum Zitat Mercuri E, Pichiecchio A, Counsell S, Allsop J, Cini C, Jungbluth H et al (2002) A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 6(6):305–307CrossRefPubMed Mercuri E, Pichiecchio A, Counsell S, Allsop J, Cini C, Jungbluth H et al (2002) A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 6(6):305–307CrossRefPubMed
17.
Zurück zum Zitat Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP et al (2013) Diagnostic odyssey of patients with myotonic dystrophy. J Neurol 260(10):2497–2504CrossRefPubMedPubMedCentral Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP et al (2013) Diagnostic odyssey of patients with myotonic dystrophy. J Neurol 260(10):2497–2504CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Rakocevic-Stojanovic V, Peric S, Basta I, Dobricic V, Ralic V, Kacar A et al (2015) Variability of multisystemic features in myotonic dystrophy type 1—lessons from Serbian registry. Neurol Res 37(11):939–944CrossRefPubMed Rakocevic-Stojanovic V, Peric S, Basta I, Dobricic V, Ralic V, Kacar A et al (2015) Variability of multisystemic features in myotonic dystrophy type 1—lessons from Serbian registry. Neurol Res 37(11):939–944CrossRefPubMed
19.
Zurück zum Zitat Coté C, Hiba B, Hebert LJ, Vial C, Remec JF, Janier M et al (2011) MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci 38(1):112–118CrossRefPubMed Coté C, Hiba B, Hebert LJ, Vial C, Remec JF, Janier M et al (2011) MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci 38(1):112–118CrossRefPubMed
20.
Zurück zum Zitat Serratrice G, Pou-Serradel A, Pellissier JF, Roux H, Lamarco-Civro J, Pouget J (1985) Chronic neurogenic quadriceps amyotrophies. J Neurol 232(3):150–153CrossRefPubMed Serratrice G, Pou-Serradel A, Pellissier JF, Roux H, Lamarco-Civro J, Pouget J (1985) Chronic neurogenic quadriceps amyotrophies. J Neurol 232(3):150–153CrossRefPubMed
21.
Zurück zum Zitat Castillo J, Pumar JM, Rodríguez JR, Prieto JM, Arrojo L, Martínez F et al (1993) Magnetic resonance imaging of muscles in myotonic dystrophy. Eur J Radiol 17(3):141–144CrossRefPubMed Castillo J, Pumar JM, Rodríguez JR, Prieto JM, Arrojo L, Martínez F et al (1993) Magnetic resonance imaging of muscles in myotonic dystrophy. Eur J Radiol 17(3):141–144CrossRefPubMed
22.
Zurück zum Zitat Fleckenstein JL (2000) MRI of neuromuscular disease: the basics. Semin Musculoskelet Radiol 4(4):393–419CrossRefPubMed Fleckenstein JL (2000) MRI of neuromuscular disease: the basics. Semin Musculoskelet Radiol 4(4):393–419CrossRefPubMed
23.
Zurück zum Zitat Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C et al (2011) Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet 19(7):776–782CrossRefPubMedPubMedCentral Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C et al (2011) Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet 19(7):776–782CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Sugie K, Sugie M, Taoka T, Tonomura Y, Kumazawa A, Izumi T et al (2015) Characteristic MRI findings of upper limb muscle involvement in myotonic dystrophy type 1. PLoS One 10(4):e0125051CrossRefPubMedPubMedCentral Sugie K, Sugie M, Taoka T, Tonomura Y, Kumazawa A, Izumi T et al (2015) Characteristic MRI findings of upper limb muscle involvement in myotonic dystrophy type 1. PLoS One 10(4):e0125051CrossRefPubMedPubMedCentral
Metadaten
Titel
Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies
verfasst von
Stojan Peric
Ruzica Maksimovic
Bojan Banko
Milica Durdic
Bogdan Bjelica
Ivo Bozovic
Yunus Balcik
Jovan Pesovic
Dusanka Savic-Pavicevic
Vidosava Rakocevic-Stojanovic
Publikationsdatum
29.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 9/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8574-0

Weitere Artikel der Ausgabe 9/2017

Journal of Neurology 9/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.